Using Probiotics in Gastrointestinal Disorders

Authors:

Abstract
Accumulating data have strongly linked gut microbes to human health. Accordingly, manipulating intestinal microbiota holds promise as a potential treatment for restoring health. Although antibiotics have been the primary clinical choice for achieving this objective, supplementing the gastrointestinal microbiota with probiotics—or encouraging their growth with prebiotics—is now widely used as an alternative approach. Among gastrointestinal disorders, data of varying quality support the use of probiotics in preventing and treating diarrhea, inflammatory bowel disease (particularly pouchitis), irritable bowel syndrome, and liver disease. Although some data are indeed promising, the profusion of probiotic products and the fact that species, strain, and formulation all clearly influence efficacy have led to significant confusion regarding the best choice for different indications. Although sufficient evidence is not currently available to provide a clear guidance on the best probiotic for a particular clinical indication, key scientific concepts are now emerging. Building on these concepts, this review will provide practical information on the use of these products in clinical practice.

This publication has 46 references indexed in Scilit: